Cargando…
Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer
Androgen deprivation therapy (ADT) is recommended for the treatment of advanced prostate cancer. Inadequate suppression of testosterone while on ADT poses a clinical challenge and requires evaluation of multiple potential causes, including adrenal virilizing disorders. We present 2 cases of elderly...
Autores principales: | Kinaan, Mustafa, Hamidi, Oksana, Yau, Hanford, Courtney, Kevin D, Eraslan, Akin, Simon, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692538/ https://www.ncbi.nlm.nih.gov/pubmed/33294761 http://dx.doi.org/10.1210/jendso/bvaa158 |
Ejemplares similares
-
MON-362 Undiagnosed Non-classic Congenital Adrenal Hyperplasia as a Driving Force for Persistent Hyperandrogenemia in Prostate Cancer
por: Awosanya, Tiwa, et al.
Publicado: (2019) -
Androgens correlate with increased erythropoiesis in women with congenital adrenal hyperplasia
por: Karunasena, Nayananjani, et al.
Publicado: (2016) -
SAT-566 Avoiding the Heartache: A Case of Familial Hypercholesterolemia
por: Kinaan, Mustafa, et al.
Publicado: (2020) -
A case of androgen-secreting adrenal carcinoma with non-classical congenital adrenal hyperplasia
por: Varma, Tarun, et al.
Publicado: (2013) -
Modified-Release and Conventional Glucocorticoids and Diurnal Androgen Excretion in Congenital Adrenal Hyperplasia
por: Jones, Christopher M., et al.
Publicado: (2016)